Real-world use of once-weekly semaglutide in patients with type 2 diabetes at an outpatient clinic in Spain

Real-world use of once-weekly semaglutide in patients with type 2 diabetes at an outpatient clinic in Spain

ObjectivesTo investigate the use of once-weekly semaglutide in a real population of people with type 2 diabetes mellitus (T2DM) in three Spanish hospitals.MethodAn observational, retrospective and multicenter clinical study was designed that included 166 participants with T2DM, distinguishing betwee...

Full description

Bibliographic Details
Main Authors: Maria Dolores Garcia de Lucas, Jose Pablo Miramontes-González, Beatriz Avilés-Bueno, Ana Isabel Jiménez-Millán, Francisco Rivas-Ruiz, Luis M. Pérez-Belmonte
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-09-01
Series:Frontiers in Endocrinology
Subjects:
once-weekly semaglutide
T2DM
HbA1c
body weight
real-world use
Online Access:https://www.frontiersin.org/articles/10.3389/fendo.2022.995646/full

Internet

https://www.frontiersin.org/articles/10.3389/fendo.2022.995646/full

Similar Items